
Dacoplice 15mg Tablet 30s
by Pfizer Ltd
Out of Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to
- It contains Dacomitinib, a targeted therapy medication used to treat certain types of non-small cell lung cancer (NSCLC).
- Dacomitinib is a tyrosine kinase inhibitor (TKI) that targets specific proteins involved in the growth and spread of cancer cells.
- It is typically prescribed for patients with advanced NSCLC who have specific genetic mutations (such as EGFR mutations).
Dacomitinib: Dacomitinib is a tyrosine kinase inhibitor that specifically targets and blocks the activity of the epidermal growth factor receptor (EGFR). EGFR is a protein that, when mutated, can promote the growth and spread of cancer cells.
- Dosage: Follow the dosage prescribed by your oncologist. The typical dose is one tablet taken once daily.
- Administration: Take the tablet orally with or without food.
- Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet.
- Take the medication at the same time each day for the best results.
- Inform your doctor if you have any known allergies to Dacomitinib or any other ingredients in the tablet. Also, inform them of any other medications you are taking, especially those affecting liver enzymes.
- Regular monitoring of liver function, kidney function, and other vital signs is necessary during treatment to detect and manage potential side effects early.
- Targets and inhibits specific proteins involved in the growth of cancer cells, leading to a reduction in tumor size and progression.
- Provides a targeted approach to treatment, particularly effective in patients with EGFR mutations.
USES IN
- NON-SMALL CELL LUNG CANCER
- Diarrhea
- Nail disorder
- Stomatitis (Inflammation of the mouth)
- Decreased appetite
- If you miss a dose, take it as soon as you remember.
- If it is less than 12 hours until your next dose, skip the missed dose and continue with your regular schedule.
- Do not take a double dose to make up for the missed one.
Health And Lifestyle
- Proton Pump Inhibitors (PPIs)
- Strong CYP2D6 Inhibitors
- Antacids

Non-Small Cell Lung Cancer (NSCLC): NSCLC is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. It includes several subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
Safety Advice For
- High risk
- Moderate risk
- Safe
There is limited information available on the use of this medication.
There is limited information available on the use of this medication.
It is not known whether it is safe to consume alcohol with this medication.
It is not known whether this medication alters the ability to drive.
Information regarding the use of this medication during pregnancy is not available.
Information regarding the use of this medication during breastfeeding is not available.
Written By
Pranav ayush
MBA in Pharmaceutical
Content Updated on
Thursday, 29 August, 2024
